ATAI
Atai Life Sciences Nv
$1.28
Earnings Summary
Revenue | $0.17Mn |
Net Profits | $-33.04Mn |
Net Profit Margins | -19210.47% |
Highlights
Atai Life Sciences Nv’s revenue jumped 1.18% since last year same period to $0.17Mn in the Q2 2023. On a quarterly growth basis, Atai Life Sciences Nv has generated 364.86% jump in its revenue since last 3-months.
Atai Life Sciences Nv’s net profit jumped 9.77% since last year same period to $-33.04Mn in the Q2 2023. On a quarterly growth basis, Atai Life Sciences Nv has generated -0.15% fall in its net profits since last 3-months.
Atai Life Sciences Nv’s net profit margin jumped 10.81% since last year same period to -19210.47% in the Q2 2023. On a quarterly growth basis, Atai Life Sciences Nv has generated 78.46% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Atai Life Sciences Nv post its latest quarter earnings
EPS Estimate Current Quarter | -0.21 |
EPS Estimate Current Year | -0.21 |
Highlights
Atai Life Sciences Nv’s earning per share (EPS) estimates for the current quarter stand at -0.21 - a 7.71% jump from last quarter’s estimates.
Atai Life Sciences Nv’s earning per share (EPS) estimates for the current year stand at -0.21.
Key Ratios
Key ratios of the Atai Life Sciences Nv post its Q3 2023 earnings
Earning Per Share (EPS) | 0 |
Highlights
Atai Life Sciences Nv’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2023. This indicates that the Atai Life Sciences Nv has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-05-11 | -0.25 | 0 | 100% |
2023-08-10 | -0.23 | 0 | 100% |
2023-11-13 | -0.21 | 0 | 100% |
₹0 US Stocks a/c Opening Fee